Ovarian Cancer: Bevacizumab as Adjuvant Treatment—Not Yet

被引:0
|
作者
Amit Agarwal
机构
[1] B L Kapoor Memorial Hospital,
关键词
Bevacizumab (BEV); High-risk Ovarian Cancer; Post-progression Treatment; Significant Residual Disease; Improved Progression Free Survival;
D O I
10.1007/s40944-017-0165-6
中图分类号
学科分类号
摘要
引用
收藏
页码:9 / 10
页数:1
相关论文
共 50 条
  • [1] Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the US Medicare system
    Walter, A.
    Geisler, J.
    Manahan, K.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S110 - S111
  • [2] Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the US Medicare system
    Walter, A.
    Manahan, K.
    Labarge, D.
    Phibbs, G.
    Geisler, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S15 - S15
  • [3] Bevacizumab in the treatment of ovarian cancer
    Han, Ernest S.
    Monk, Bradley J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (10) : 1339 - 1345
  • [4] Bevacizumab in the Treatment of Ovarian Cancer
    Florian Heitz
    Philipp Harter
    Jana Barinoff
    Bianca Beutel
    Paevi Kannisto
    Jacek P. Grabowski
    Julia Heitz
    Christian Kurzeder
    Andreas du Bois
    [J]. Advances in Therapy, 2012, 29 : 723 - 735
  • [5] Bevacizumab in the treatment of ovarian cancer
    Eskander, Ramez N.
    Randall, Leslie M.
    [J]. BIOLOGICS-TARGETS & THERAPY, 2011, 5 : 1 - 5
  • [6] Bevacizumab in the Treatment of Ovarian Cancer
    Heitz, Florian
    Harter, Philipp
    Barinoff, Jana
    Beutel, Bianca
    Kannisto, Paevi
    Grabowski, Jacek P.
    Heitz, Julia
    Kurzeder, Christian
    du Bois, Andreas
    [J]. ADVANCES IN THERAPY, 2012, 29 (09) : 723 - 735
  • [7] Bevacizumab in the Treatment of Metastatic Breast Cancer Bevacizumab in Breast Cancer: The Best Is Yet to Come?
    Traina, Tiffany A.
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (04): : 327 - 332
  • [8] IMPACT OF ADJUVANT BEVACIZUMAB ON LYMPHOCELES AND SURVIVAL IN ADVANCED OVARIAN CANCER
    Perrin, M.
    Bentivegna, E.
    Bonneau, C.
    Uzan, C.
    Leary, A.
    Pautier, P.
    Genestie, C.
    Morice, P.
    Gouy, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 527 - 527
  • [9] Evaluation of Bevacizumab in the Adjuvant Treatment of Colon Cancer
    Saltz, Leonard
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (03) : 109 - 110
  • [10] Tailored treatment for ovarian cancer: are we there yet?
    Cristiana Sessa
    Gianluca Del Conte
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 80 - 82